Cited by 33Neuroinflammation and Neurodegeneration MechanismsChemokine receptors and signalingNeurogenesis and neuroplasticity mechanisms

Functional analysis of CX3CR1 in human induced pluripotent stem (iPS) cell‐derived microglia‐like cells

Open access
Murai, Nobuhito, Mitalipova, Maisam, Jaenisch, Rudolf·2020·European Journal of Neuroscience

Abstract

Microglia are the primary immune cells of the central nervous system and crucial to proper development and maintenance of the brain. Microglia have been recognized to be associated with neurodegenerative diseases and neuroinflammatory disorders. CX3C chemokine receptor 1 (CX3CR1), which is specifically expressed in microglia, regulates microglia homeostatic functions such as microglial activation and is downregulated in aged brain and disease‐associated microglia in rodents, yet its role in human microglia is not fully understood. In this study, we investigated the function of CX3CR1 in human microglia using human induced pluripotent stem (iPS) cell‐derived microglia‐like cells. Human iPS cell‐derived microglia‐like cells expressed microglial markers and showed an activated state and phagocytic activity. Using CRISPR/Cas9 genome editing, we deleted CX3CR1 in human iPS cells and found increased inflammatory responses and phagocytic activity in mutant as compared to wild‐type microglia‐like cells. In addition, the CX3C chemokine ligand 1 (CX3CL1, a ligand for CX3CR1) significantly decreased the upregulation of IL‐6 by lipopolysaccharide stimulation in human iPS cell‐derived microglia‐like cells. These results suggest that CX3CR1 in human microglia may contribute to microglial homeostasis by regulating inflammatory response and phagocytosis.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1111/ejn.14879

Cites

9 of 9 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 29

  1. Abud EM, Ramirez RN, Martinez ES, Healy LM, Nguyen CHH, Newman SA, … Blurton-Jones M (2017). iPSC-derived human microglia-like cells to study neurological diseases. Neuron, 94, 278– 293. 10.1016/j.neuron.2017.03.042 28426964 PMC5482419 · DOI · Paper page
  2. Airas L, Nylund M, & Rissanen E (2018). Evaluation of microglial activation in multiple sclerosis patients using positron emission tomography. Frontiers in Neurology, 9, 181. 10.3389/fneur.2018.00181 29632509 PMC5879102 · DOI
  3. Bachstetter AD, Morganti JM, Jernberg J, Schlunk A, Mitchell SH, Brewster KW, … Gemma C (2011). Fractalkine and CX 3 CR1 regulate hippocampal neurogenesis in adult and aged rats. Neurobiology of Aging, 32, 2030– 2044. 10.1016/j.neurobiolaging.2009.11.022 20018408 PMC2889032 · DOI · Paper page
  4. Brownjohn PW, Smith J, Solanki R, Lohmann E, Houlden H, Hardy J, … Livesey FJ (2018). Functional studies of missense TREM2 mutations in human stem cell-derived microglia. Stem Cell Reports, 10, 1294– 1307. 10.1016/j.stemcr.2018.03.003 29606617 PMC5998752 · DOI · Paper page
  5. Buttgereit A, Lelios I, Yu X, Vrohlings M, Krakoski NR, Gautier EL, … Greter M (2016). Sall1 is a transcriptional regulator defining microglia identity and function. Nature Immunology, 17, 1397– 1406. 10.1038/ni.3585 27776109 · DOI · Paper page
  6. Chan G, White CC, Winn PA, Cimpean M, Replogle JM, Glick LR, … De Jager PL (2015). CD33 modulates TREM2: Convergence of Alzheimer loci. Nature Neuroscience, 18, 1556– 1558. 10.1038/nn.4126 26414614 PMC4682915 · DOI · Paper page
  7. Douvaras P, Sun B, Wang M, Kruglikov I, Lallos G, Zimmer M, … Fossati V (2017). Directed differentiation of human pluripotent stem cells to microglia. Stem Cell Reports, 8, 1516– 1524. 10.1016/j.stemcr.2017.04.023 28528700 PMC5470097 · DOI · Paper page
  8. Gerhard A (2016). TSPO imaging in parkinsonian disorders. Clinical and Translational Imaging, 4, 183– 190. 10.1007/s40336-016-0171-1 27340650 PMC4870295 · DOI
  9. Haenseler W, Sansom SN, Buchrieser J, Newey SE, Moore CS, Nicholls FJ, … Cowley SA (2017). A highly efficient human pluripotent stem cell microglia model displays a neuronal-co-culture-specific expression profile and inflammatory response. Stem Cell Reports, 8, 1727– 1742. 10.1016/j.stemcr.2017.05.017 28591653 PMC5470330 · DOI · Paper page
  10. Harrison JK, Jiang Y, Chen S, Xia Y, Maciejewski D, McNamara RK, … Feng L (1998). Role for neuronally derived fractalkine in mediating interactions between neurons and CX3CR1-expressing microglia. Proceedings of the National Academy of Sciences, USA, 95, 10896– 10901. 10.1073/pnas.95.18.10896 PMC27992 9724801 · DOI · Paper page
  11. Hasselmann J, Coburn MA, England W, Figueroa Velez DX, Kiani Shabestari S, Tu CH, … Blurton-Jones M (2019). Development of a chimeric model to study and manipulate human microglia in vivo. Neuron, 103, 1016– 1033. 31375314 PMC7138101
  12. Keren-Shaul H, Spinrad A, Weiner A, Matcovitch-Natan O, Dvir-Szternfeld R, Ulland TK, … Amit I (2017). A unique microglia type associated with Restricting development of Alzheimer’s disease. Cell, 169, 1276– 1290. 10.1016/j.cell.2017.05.018 28602351 · DOI · Paper page
  13. Korvatska O, Leverenz JB, Jayadev S, McMillan P, Kurtz I, Guo X, … Bird TD (2015). R47H variant of TREM2 associated with Alzheimer disease in a large late-onset family: Clinical, genetic, and neuropathological study. JAMA Neurology, 72, 920– 927. 26076170 PMC4825672
  14. Krasemann S, Madore C, Cialic R, Baufeld C, Calcagno N, El Fatimy R, … Butovsky O (2017). The TREM2-APOE pathway drives the transcriptional phenotype of dysfunctional microglia in neurodegenerative diseases. Immunity, 47, 566– 581. 10.1016/j.immuni.2017.08.008 28930663 PMC5719893 · DOI · Paper page
  15. Mecca C, Giambanco I, Donato R, & Arcuri C (2018). Microglia and aging: The role of the TREM2-DAP12 and CX3CL1-CX3CR1 axes. International Journal of Molecular Sciences, 19, 318. 10.3390/ijms19010318 PMC5796261 29361745 · DOI
  16. Mizuno T, Kawanokuchi J, Numata K, & Suzumura A (2003). Production and neuroprotective functions of fractalkine in the central nervous system. Brain Research, 979, 65– 70. 10.1016/S0006-8993(03)02867-1 12850572 · DOI
  17. Muffat J, Li Y, Yuan B, Mitalipova M, Omer A, Corcoran S, … Jaenisch R (2016). Efficient derivation of microglia-like cells from human pluripotent stem cells. Nature Medicine, 22, 1358– 1367. 10.1038/nm.4189 PMC5101156 27668937 · DOI · Paper page
  18. Nakatomi Y, Mizuno K, Ishii A, Wada Y, Tanaka M, Tazawa S, … Watanabe Y (2014). Neuroinflammation in patients with chronic fatigue syndrome/myalgic encephalomyelitis: An 11C-(R)-PK11195 PET study. Journal of Nuclear Medicine, 55, 945– 950. 10.2967/jnumed.113.131045 24665088 · DOI
  19. Pandya H, Shen MJ, Ichikawa DM, Sedlock AB, Choi Y, Johnson KR, … Park JK (2017). Differentiation of human and murine induced pluripotent stem cells to microglia-like cells. Nature Neuroscience, 20, 753– 759. 10.1038/nn.4534 28253233 PMC5404968 · DOI · Paper page
  20. Ran FA, Hsu PD, Wright J, Agarwala V, Scott DA, & Zhang F (2013). Genome engineering using the CRISPR-Cas9 system. Nature Protocols, 8, 2281– 2308. 10.1038/nprot.2013.143 24157548 PMC3969860 · DOI · Paper page
  21. Salter MW, & Stevens B (2017). Microglia emerge as central players in brain disease. Nature Medicine, 23, 1018– 1027. 10.1038/nm.4397 28886007 · DOI · Paper page
  22. Schafer DP, & Stevens B (2015). Microglia function in central nervous system development and plasticity. Cold Spring Harbor Perspectives in Biology, 7, a020545. 10.1101/cshperspect.a020545 26187728 PMC4588063 · DOI · Paper page
  23. Setiawan E, Attwells S, Wilson AA, Mizrahi R, Rusjan PM, Miler L, … Meyer JH (2018). Association of translocator protein total distribution volume with duration of untreated major depressive disorder: A cross-sectional study. Lancet Psychiatry, 6, 339– 347. 10.1016/S2215-0366(18)30048-8 29496589 · DOI
  24. Soldner F, & Jaenisch R (2018). Stem cells, genome editing, and the path to translational medicine. Cell, 175, 615– 632. 10.1016/j.cell.2018.09.010 30340033 PMC6461399 · DOI
  25. Svoboda DS, Barrasa MI, Shu J, Rietjens R, Zhang S, Mitalipova M, … Jaenisch R (2019). Human iPSC-derived microglia assume a primary microglia-like state after transplantation into the neonatal mouse brain. Proceedings of the National Academy of Sciences, USA, 116, 25293– 25303. 10.1073/pnas.1913541116 PMC6911218 31772018 · DOI
  26. Takahashi K, Tanabe K, Ohnuki M, Narita M, Ichisaka T, Tomoda K, & Yamanaka S (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell, 131, 861– 872. 10.1016/j.cell.2007.11.019 18035408 · DOI · Paper page
  27. Tremblay MÈ, Stevens B, Sierra A, Wake H, Bessis A, & Nimmerjahn A (2011). The role of microglia in the healthy brain. Journal of Neuroscience, 31, 16064– 16069. 10.1523/JNEUROSCI.4158-11.2011 22072657 PMC6633221 · DOI · Paper page
  28. Wright-Jin EC, & Gutmann DH (2019). Microglia as dynamic cellular mediators of brain function. Trends in Molecular Medicine, 25, 967– 979. 10.1016/j.molmed.2019.08.013 31597593 PMC6829057 · DOI
  29. Zujovic V, Benavides J, Vigé X, Carter C, & Taupin V (2000). Fractalkine modulates TNF-alpha secretion and neurotoxicity induced by microglial activation. Glia, 29, 305– 315. 10652441

Cited by

Sorted by citations

Authors
Murai, N., Mitalipova, M., & Jaenisch, R.
Affiliations
  • Astellas Pharma (Japan) (JP)
  • Whitehead Institute for Biomedical Research (US)
Corresponding author
Jaenisch, Rudolf
Venue
European Journal of Neuroscience
Publisher
Wiley
Published
2020-09-14
Volume
52
Issue
7
Pages
3667-3678
ISSN
  • 0953-816X (ISSN-L)
  • 1460-9568
OpenAlex
W3037767942
Cited by
33
References
9
Citations by year
2026: 5 · 2025: 3 · 2024: 4 · 2023: 4 · 2022: 5 · 2021: 11 · 2020: 1
FWCI
2.03
Type
journal article
Language
en
Open access
Locations
  • European Journal of Neuroscience (publishedVersion)
  • PubMed (publishedVersion)
  • PubMed Central (acceptedVersion)
  • DSpace@MIT (Massachusetts Institute of Technology) (submittedVersion, cc-by-nc-sa)
Funders
  • National Institutes of Health (1R01‐NS088538, 5R01‐MH104610, R37HD045022)
  • Cure Alzheimer's Fund
  • Novo Nordisk
Topics
  • Life Sciences › Neuroscience › Neurology › Neuroinflammation and Neurodegeneration Mechanisms
  • Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
  • Life Sciences › Neuroscience › Developmental Neuroscience › Neurogenesis and neuroplasticity mechanisms
Keywords
CX3CR1, fractalkine, microglia, microglial homeostasis, microglial activation, phagocytosis, neuroinflammation, interleukin-6, lipopolysaccharide, CRISPR/Cas9 knockout, human microglia
MeSH terms
CX3C Chemokine Receptor 1, Aged, Brain, Humans, Phagocytosis, Microglia, Induced Pluripotent Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review